Clinical Trials List
Protocol Number3082-CL-0301
Not yet recruiting
2026-07-26 - 2029-10-29
Phase III
Not yet recruiting1
-
Trial Applicant
Astellas Pharma Inc.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/01
Investigators and Locations
Co-Principal Investigator
- Chang-Fang Chiu 無
- Yu-Min Liao 無
- 王秀慈 無
- Che-Hung Lin 無
- 陳珈妤 無
- Chi-Ching Chen 無
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
614 participants
